Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Ten years with biosimilar rhGH in clinical practice in Sweden – experience from the prospective PATRO children and adult studies

Fig. 3

HSDS of biosimilar rhGH treatment over 3 years for pre-pubertal rhGH treatment-naïve GHD, SGA, and TS patients who are younger than 10 years (girls) or 11 years (boys). GHD growth hormone deficiency, HSDS height standard deviation score, rhGH recombinant human growth hormone, SD standard deviation, SGA small for gestational age, TS Turner syndrome

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us